Biomarkers of aging with prognostic and predictive value in non-oncological diseases

Current Medicinal Chemistry

Volumn 16, Issue 27, 2009, Pages 3469-3475

  Koppelstaetter, Christian ^a   Kern, Georg ^a   Mayer, Gert ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Aging; Biomarkers; BoAs; Outcome; Predictive; Prognostic; Telomere

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BIOLOGICAL MARKER; CYCLIN DEPENDENT KINASE INHIBITOR; TELOMERASE;

AGING; APLASTIC ANEMIA; CELL AGING; CORONARY ARTERY DISEASE; DEMENTIA; DIABETES MELLITUS; DNA DETERMINATION; DNA HYBRIDIZATION; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; KIDNEY DISEASE; MORTALITY; OSTEOPOROSIS; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PREDICTION; PROGNOSIS; RESTRICTION FRAGMENT; REVIEW; RISK FACTOR; TELOMERE;

AGING; ANEMIA, APLASTIC; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DEMENTIA; DIABETES MELLITUS; EARLY DIAGNOSIS; HUMANS; KIDNEY DISEASES; OSTEOPOROSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TELOMERE;

EID: 70450194975     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986709789057644     Document Type: Review

References (83)

1. Mueller, C.; Muller, B.; Perruchoud, A.P. Biomarkers: past, present, and future. Swiss Med. Wkly, 2008, 138(15-16), 225-229.
2. Vallbohmer, D.; Lenz, H.J. Predictive and prognostic molecular markers in outcome of esophageal cancer. Dis Esophagus, 2006, 19(6), 425-432. (Pubitemid 44644677)
3. Cianfrocca, M.; Goldstein, L.J. Prognostic and predictive factors in early-stage breast cancer. Oncologist, 2004, 9(6), 606-616. (Pubitemid 39546402)
4. Gosse, P. Heart rate: risk factor, risk marker. Ann Cardiol Angeiol (Paris), 1998, 47(6), 438-439. (Pubitemid 28292392)
5. Baker, G.T.; 3rd; Sprott, R.L. Biomarkers of aging. Exp Gerontol, 1988, 23(4-5), 223-239.
6. Hayflick, L. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res., 1965, 37, 614-636.
7. Collado, M.; Blasco, M.A.; Serrano, M. Cellular senescence in cancer and aging. Cell, 2007, 130(2), 223-233.
8. Campisi, J.; Kim, S.H.; Lim, C.S.; Rubio, M. Cellular senescence, cancer and aging: the telomere connection. Exp. Gerontol., 2001, 36(10), 1619-1637. (Pubitemid 32982869)
9. Campisi, J. Cancer, aging and cellular senescence. In Vivo, 2000, 14(1), 183-188.
10. Bisoffi, M.; Heaphy, C.M.; Griffith, J.K. Telomeres: prognostic markers for solid tumors. Int. J. Cancer, 2006, 119(10), 2255-2260.
11. Ram, R.; Uziel, O.; Lahav, M. The importance of the telomere and telomerase system in hematological malignancies. Leuk Lymphoma, 2005, 46(8), 1121-1135. (Pubitemid 41087016)
12. Sebastian, S.; Grammatica, L.; Paradiso, A. Potential biomarkers of ageing. Telomeres, telomerase and oral cancer (Review) Int. J. Oncol., 2005, 27(6), 1583-1596.
13. Simm, A.; Nass, N.; Bartling, B.; Hofmann, B.; Silber, R.E.; Navarrete Santos, A. Potential biomarkers of ageing. Biol. Chem., 2008, 389(3), 257-265.
14. Johnson, T.E. Recent results: biomarkers of aging. Exp. Gerontol., 2006, 41(12), 1243-1246.
15. Rando, T.A. Prognostic value of telomere length: the long and short of it. Ann. Neurol., 2006, 60(2), 155-157. (Pubitemid 44182389)
16. von Zglinicki, T.; Martin-Ruiz, C.M. Telomeres as biomarkers for ageing and age-related diseases. Curr. Mol. Med., 2005, 5(2), 197-203.
17. Jiang, H.; Ju, Z.; Rudolph, K.L. Telomere shortening and ageing. Z Gerontol. Geriatr., 2007, 40(5), 314-324.
18. Baird, D.M. Telomeres. Exp. Gerontol., 2006, 41(12), 1223-1227.
19. Baird, D.M. Telomeres II. Exp. Gerontol., 2008, 43(1), 15-19.
20. Bekaert, S.; De Meyer, T.; Van Oostveldt, P. Telomere attrition as ageing biomarker. Anticancer Res., 2005, 25(4), 3011-3021.
21. Blackburn, E.H.; Gall, J.G. A tandemly repeated sequence at the termini of the extrachromosomal ribosomal RNA genes in Tetrahymena. J. Mol. Biol., 1978, 120(1), 33-53. (Pubitemid 8312910)
22. Moyzis, R.K.; Buckingham, J.M.; Cram, L.S.; Dani, M.; Deaven, L.L.; Jones, M.D.; Meyne, J.; Ratliff, R.L.; Wu, J.R. A highly conserved repetitive DNA sequence(TTAGGG)n, present at the telomeres of human chromosomes. Proc. Natl. Acad. Sci. USA, 1988, 85(18), 6622-6626.
23. von Zglinicki, T.; Pilger, R.; Sitte, N. Accumulation of single-strand breaks is the major cause of telomere shortening in human fibroblasts. Free Radic. Biol. Med., 2000, 28(1), 64-74. (Pubitemid 30045574)
24. Nakamura, Y.; Hirose, M.; Matsuo, H.; Tsuyama, N.; Kamisango, K.; Ide, T. Simple, rapid, quantitative, and sensitive detection of telomere repeats in cell lysate by a hybridization protection assay. Clin. Chem., 1999, 45(10), 1718-1724.
25. Cawthon, R.M. Telomere measurement by quantitative PCR. Nucleic Acids Res., 2002, 30(10), e47.
26. Cawthon, R.M. Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res., 2009, 37(3), e21.
27. Koppelstaetter, C.; Jennings, P.; Hochegger, K.; Perco, P.; Ischia, R.; Karkoszka, H.; Mayer, G. Effect of tissue fixatives on telomere length determination by quantitative PCR. Mech. Ageing Dev., 2005, 126(12), 1331-1333. (Pubitemid 41572251)
28. O'Callaghan, N.; Dhillon, V.; Thomas, P.; Fenech, M. A quantitative realtime PCR method for absolute telomere length. Biotechniques, 2008, 44(6), 807-809. (Pubitemid 351839149)
29. Baird, D.M.; Rowson, J.; Wynford-Thomas, D.; Kipling, D. Extensive allelic variation and ultrashort telomeres in senescent human cells. Nat. Genet., 2003, 33(2), 203-207. (Pubitemid 36177075)
30. Lansdorp, P.M.; Verwoerd, N.P.; van de Rijke, F.M.; Dragowska, V.; Little, M.T.; Dirks, R.W.; Raap, A.K.; Tanke, H.J. Heterogeneity in telomere length of human chromosomes. Hum. Mol. Genet., 1996, 5(5), 685-691.
31. Corey, D.R. Peptide nucleic acids: expanding the scope of nucleic acid recognition. Trends Biotechnol., 1997, 15(6), 224-229. (Pubitemid 27242748)
32. de Pauw, E.S.; Verwoerd, N.P.; Duinkerken, N.; Willemze, R.; Raap, A.K.; Fibbe, W.E.; Tanke, H.J. Assessment of telomere length in hematopoietic interphase cells using in situ hybridization and digital fluorescence microscopy. Cytometry, 1998, 32(3), 163-169.
33. Rufer, N.; Dragowska, W.; Thornbury, G.; Roosnek, E.; Lansdorp, P.M. Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry. Nat. Biotechnol., 1998, 16(8), 743-747. (Pubitemid 28363755)
34. Baerlocher, G.M.; Mak, J.; Tien, T.; Lansdorp, P.M. Telomere length measurement by fluorescence in situ hybridization and flow cytometry: tips and pitfalls. Cytometry, 2002, 47(2), 89-99.
35. Baerlocher, G.M.; Vulto, I.; de Jong, G.; Lansdorp, P.M. Flow cytometry and FISH to measure the average length of telomeres (flow FISH). Nat. Protoc., 2006, 1(5), 2365-2376.
36. O'Sullivan, J.N.; Bronner, M.P.; Brentnall, T.A.; Finley, J.C.; Shen, W.T.; Emerson, S.; Emond, M.J.; Gollahon, K.A.; Moskovitz, A.H.; Crispin, D.A.; Potter, J.D.; Rabinovitch, P.S. Chromosomal instability in ulcerative colitis is related to telomere shortening. Nat. Genet., 2002, 32(2), 280-284.
37. Meeker, A.K.; Gage, W.R.; Hicks, J.L.; Simon, I.; Coffman, J.R.; Platz, E.A.; March, G.E.; De Marzo, A.M. Telomere length assessment in human archival tissues: combined telomere fluorescence in situ hybridization and immunostaining. Am. J. Pathol., 2002, 160(4), 1259-1268.
38. Wong, H.; Riabowol, K. Differential CDK-inhibitor gene expression in aging human diploid fibroblasts. Exp. Gerontol., 1996, 31(1-2), 311-325. (Pubitemid 26079682)
39. Weng, N.P. Telomere and adaptive immunity. Mech. Ageing Dev., 2008, 129(1-2), 60-66.
40. Kim, N.W.; Piatyszek, M.A.; Prowse, K.R.; Harley, C.B.; West, M.D.; Ho, P.L.; Coviello, G.M.; Wright, W.E.; Weinrich, S.L.; Shay, J.W. Specific association of human telomerase activity with immortal cells and cancer. Science, 1994, 266(5193), 2011-2015.
41. Thornalley, P.J. Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems -role in ageing and disease. Drug Metab. Drug Interact., 2008, 23(1-2), 125-150.
42. Brownlee, M. Biochemistry and molecular cell biology of diabetic complications. Nature, 2001, 414(6865), 813-820. (Pubitemid 34000785)
43. Horiuchi, S.; Araki, N.; Morino, Y. Immunochemical approach to characterize advanced glycation end products of the Maillard reaction: evidence for the presence of a common structure. J. Biol. Chem., 1991, 266(12), 7329-7332.
44. Makita, Z.; Vlassara, H.; Cerami, A.; Bucala, R. Immunochemical detection of advanced glycosylation end products in vivo. J. Biol. Chem., 1992, 267(8), 5133-5138.
45. Ball, S.E.; Gibson, F.M.; Rizzo, S.; Tooze, J.A.; Marsh, J.C.; Gordon-Smith, E.C. Progressive telomere shortening in aplastic anemia. Blood, 1998, 91(10), 3582-3592.
46. Brummendorf, T.H.; Rufer, N.; Holyoake, T.L.; Maciejewski, J.; Barnett, M.J.; Eaves, C.J.; Eaves, A.C.; Young, N.; Lansdorp, P.M. Telomere length dynamics in normal individuals and in patients with hematopoietic stem cell-associated disorders. Ann. N.Y. Acad. Sci., 2001, 938, 293-303; discussion 303-1294
47. Lee, J.J.; Kook, H.; Chung, I.J.; Na, J.A.; Park, M.R.; Hwang, T.J.; Kwak, J.Y.; Sohn, S.K.; Kim, H.J. Telomere length changes in patients with aplastic anaemia. Br. J. Haematol., 2001, 112(4), 1025-1030.
48. Benetos, A.; Gardner, J.P.; Zureik, M.; Labat, C.; Xiaobin, L.; Adamopoulos, C.; Temmar, M.; Bean, K.E.; Thomas, F.; Aviv, A. Short telomeres are associated with increased carotid atherosclerosis in hypertensive subjects. Hypertension, 2004, 43(2), 182-185. (Pubitemid 38174171)
49. Kurz, D.J.; Kloeckener-Gruissem, B.; Akhmedov, A.; Eberli, F.R.; Buhler, I.; Berger, W.; Bertel, O.; Luscher, T.F. Degenerative aortic valve stenosis, but not coronary disease, is associated with shorter telomere length in the elderly. Arterioscler. Thromb. Vasc. Biol., 2006, 26(6), e114-117.
50. Cawthon, R.M.; Smith, K.R.; O'Brien, E.; Sivatchenko, A.; Kerber, R.A. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet, 2003, 361(9355), 393-395. (Pubitemid 36164975)
51. Brouilette, S.W.; Moore, J.S.; McMahon, A.D.; Thompson, J.R.; Ford, I.; Shepherd, J.; Packard, C.J.; Samani, N.J. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Lancet, 2007, 369(9556), 107-114.
52. Fitzpatrick, A.L.; Kronmal, R.A.; Gardner, J.P.; Psaty, B.M.; Jenny, N.S.; Tracy, R.P.; Walston, J.; Kimura, M.; Aviv, A. Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. Am. J. Epidemiol., 2007, 165(1), 14-21. (Pubitemid 46026204)
53. Farzaneh-Far, R.; Cawthon, R.M.; Na, B.; Browner, W.S.; Schiller, N.B.; Whooley, M.A., Prognostic value of leukocyte telomere length in patients with stable coronary artery disease: data from the Heart and Soul Study. Arterioscler. Thromb. Vasc. Biol., 2008, 28(7), 1379-1384.
54. Yang, Z.; Huang, X.; Jiang, H.; Zhang, Y.; Liu, H.; Qin, C.; Eisner, G.M.; Jose, P.; Rudolph, L.; Ju, Z. Short telomeres and prognosis of hypertension in a chinese population. Hypertension, 2009, 53(4), 639-645.
55. van der Harst, P.; van der Steege, G.; de Boer, R.A.; Voors, A.A.; Hall, A.S.; Mulder, M.J.; van Gilst, W.H.; van Veldhuisen, D.J. Telomere length of cir culating leukocytes is decreased in patients with chronic heart failure. J. Am. Coll. Cardiol., 2007, 49(13), 1459-1464.
56. Simm, A.; Wagner, J.; Gursinsky, T.; Nass, N.; Friedrich, I.; Schinzel, R.; Czeslik, E.; Silber, R.E.; Scheubel, R.J. Advanced glycation endproducts: a biomarker for age as an outcome predictor after cardiac surgery? Exp. Gerontol., 2007, 42(7), 668-675.
57. Jeanclos, E.; Krolewski, A.; Skurnick, J.; Kimura, M.; Aviv, H.; Warram, J.H.; Aviv, A. Shortened telomere length in white blood cells of patients with IDDM. Diabetes, 1998, 47(3), 482-486. (Pubitemid 28104214)
58. Uziel, O.; Singer, J.A.; Danicek, V.; Sahar, G.; Berkov, E.; Luchansky, M.; Fraser, A.; Ram, R.; Lahav, M. Telomere dynamics in arteries and mononuclear cells of diabetic patients: effect of diabetes and of glycemic control. Exp. Gerontol., 2007, 42(10), 971-978. (Pubitemid 47432738)
59. Busch, M.; Franke, S.; Wolf, G.; Brandstadt, A.; Ott, U.; Gerth, J.; Hunsicker, L.G.; Stein, G. The advanced glycation end product N(epsilon)- carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension. Am. J. Kidney Dis., 2006, 48(4), 571-579. (Pubitemid 44425379)
60. Busch, M.; Franke, S.; Wolf, G.; Rohde, R.D.; Stein, G. Serum levels of the advanced glycation end products Nepsilon-carboxymethyllysine and pentosidine are not influenced by treatment with the angiotensin receptor II type 1 blocker irbesartan in patients with type 2 diabetic nephropathy and hypertension. Nephron Clin. Pract., 2008, 108(4), c291-297. (Pubitemid 351704303)
61. Martin-Ruiz, C.M.; Gussekloo, J.; van Heemst, D.; von Zglinicki, T.; Westendorp, R.G. Telomere length in white blood cells is not associated with morbidity or mortality in the oldest old: a population-based study. Aging Cell, 2005, 4(6), 287-290.
62. Zekry, D.; Herrmann, F.R.; Irminger-Finger, I.; Ortolan, L.; Genet, C.; Vitale, A.M.; Michel, J.P.; Gold, G.; Krause, K.H. Telomere length is not predictive of dementia or MCI conversion in the oldest old. Neurobiol. Aging, 2008, [Epub ahead of print].
63. Panossian, L.A.; Porter, V.R.; Valenzuela, H.F.; Zhu, X.; Reback, E.; Masterman, D.; Cummings, J.L.; Effros, R.B. Telomere shortening in T cells correlates with Alzheimer's disease status. Neurobiol. Aging, 2003, 24(1), 77-84.
64. Honig, L.S.; Schupf, N.; Lee, J.H.; Tang, M.X.; Mayeux, R. Shorter telomeres are associated with mortality in those with APOE epsilon4 and dementia. Ann. Neurol., 2006, 60(2), 181-187. (Pubitemid 44182393)
65. Valdes, A.M.; Deary, I.J.; Gardner, J.; Kimura, M.; Lu, X.; Spector, T.D.; Aviv, A.; Cherkas, L.F. Leukocyte telomere length is associated with cognitive performance in healthy women. Neurobiol. Aging, 2008, [Epub ahead of print].
66. Martin-Ruiz, C.; Dickinson, H.O.; Keys, B.; Rowan, E.; Kenny, R.A.; Von Zglinicki, T. Telomere length predicts poststroke mortality, dementia, and cognitive decline. Ann. Neurol., 2006, 60(2), 174-180. (Pubitemid 44182392)
67. Bekaert, S.; Van Pottelbergh, I.; De Meyer, T.; Zmierczak, H.; Kaufman, J.M.; Van Oostveldt, P.; Goemaere, S. Telomere length versus hormonal and bone mineral status in healthy elderly men. Mech. Ageing Dev., 2005, 126(10), 1115-1122. (Pubitemid 41253863)
68. Valdes, A.M.; Richards, J.B.; Gardner, J.P.; Swaminathan, R.; Kimura, M.; Xiaobin, L.; Aviv, A.; Spector, T.D. Telomere length in leukocytes correlates with bone mineral density and is shorter in women with osteoporosis. Osteoporos Int., 2007, 18(9), 1203-1210.
69. Sanders, J.; Cauley, J.; Boudreau, R.; Zmuda, J.; Strotmeyer, E.; Opresko, P.; Hsueh, W.C.; Cawthon, R.; Li, R.; Harris, T.; Kritchevsky, S.; Newman, A. Leukocyte telomere length is not associated with bone mineral density, osteoporosis, or fracture in older adults: results from the health, aging and body composition study. J. Bone Miner Res., 2009, [Epub ahead of print].
70. Richards, J.B.; Valdes, A.M.; Gardner, J.P.; Paximadas, D.; Kimura, M.; Nessa, A.; Lu, X.; Surdulescu, G.L.; Swaminathan, R.; Spector, T.D.; Aviv, A. Higher serum vitamin D concentrations are associated with longer leukocyte telomere length in women. Am. J. Clin. Nutr., 2007, 86(5), 1420-1425. (Pubitemid 350126247)
71. Szeto, C.C.; Poon, P.Y.; Lai, F.M.; Chow, K.M.; Szeto, C.Y.; Li, P.K. Chromosomal telomere shortening of kidney cells in IgA nephropathy by the measurement of DNA in urinary sediment. Clin. Nephrol., 2005, 64(5), 337-342.
72. Koppelstaetter, C.; Schratzberger, G.; Perco, P.; Hofer, J.; Mark, W.; Ollinger, R.; Oberbauer, R.; Schwarz, C.; Mitterbauer, C.; Kainz, A.; Karkoszka, H.; Wiecek, A.; Mayer, B.; Mayer, G. Markers of cellular senescence in zero hour biopsies predict outcome in renal transplantation. Aging Cell, 2008, 7(4), 491-497 (Pubitemid 351998609)
73. McGlynn, L.M.; Stevenson, K.; Lamb, K.; Zino, S.; Brown, M.; Prina, A.; Kingsmore, D.; Shiels, P.G. Cellular senescence in pretransplant renal biopsies predicts postoperative organ function. Aging Cell, 2009, 8(1), 45-51.
74. Kimura, M.; Hjelmborg, J.V.; Gardner, J.P.; Bathum, L.; Brimacombe, M.; Lu, X.; Christiansen, L.; Vaupel, J.W.; Aviv, A.; Christensen, K. Telomere length and mortality: a study of leukocytes in elderly Danish twins. Am. J. Epidemiol., 2008, 167(7), 799-806.
75. Njajou, O.T.; Cawthon, R.M.; Damcott, C.M.; Wu, S.H.; Ott, S.; Garant, M.J.; Blackburn, E.H.; Mitchell, B.D.; Shuldiner, A.R.; Hsueh, W.C. Telomere length is paternally inherited and is associated with parental lifespan. Proc. Natl. Acad. Sci. USA, 2007, 104(29), 12135-12139.
76. Carrero, J.J.; Stenvinkel, P.; Fellstrom, B.; Qureshi, A.R.; Lamb, K.; Heimburger, O.; Barany, P.; Radhakrishnan, K.; Lindholm, B.; Soveri, I.; Nordfors, L.; Shiels, P.G. Telomere attrition is associated with inflammation, low fetuin-A levels and high mortality in prevalent haemodialysis patients. J. Intern. Med., 2008, 263(3), 302-312.
77. Epel, E.S.; Blackburn, E.H.; Lin, J.; Dhabhar, F.S.; Adler, N.E.; Morrow, J.D.; Cawthon, R.M. Accelerated telomere shortening in response to life stress. Proc. Natl. Acad. Sci. USA, 2004, 101(49), 17312-17315. (Pubitemid 39627816)
78. Ornish, D.; Lin, J.; Daubenmier, J.; Weidner, G.; Epel, E.; Kemp, C.; Magbanua, M.J.; Marlin, R.; Yglecias, L.; Carroll, P.R.; Blackburn, E.H. Increased telomerase activity and comprehensive lifestyle changes: a pilot study. Lancet Oncol., 2008, 9(11), 1048-1057.
79. Morla, M.; Busquets, X.; Pons, J.; Sauleda, J.; MacNee, W.; Agusti, A.G. Telomere shortening in smokers with and without COPD. Eur. Respir J., 2006, 27(3), 525-528.
80. Cherkas, L.F.; Hunkin, J.L.; Kato, B.S.; Richards, J.B.; Gardner, J.P.; Surdulescu, G.L.; Kimura, M.; Lu, X.; Spector, T.D.; Aviv, A. The association between physical activity in leisure time and leukocyte telomere length. Arch. Intern. Med., 2008, 168(2), 154-158. (Pubitemid 351185881)
81. Xu, Q.; Parks, C.G.; Deroo, L.A.; Cawthon, R.M.; Sandler, D.P.; Chen, H. Multivitamin use and telomere length in women. Am. J. Clin. Nutr., 2009, 89, 1857-1863
82. Riethman, H. Human telomere structure and biology. Annu. Rev. Genomics Hum. Genet., 2008, 9, 1-19.
83. Sedivy, J.M.; Shippen, D.E.; Shakirov, E.V. Surprise ending. Nat. Genet., 2003, 33(2), 114-116.